Ultrasound Market Outlook:
Ultrasound Market size was over USD 10.54 billion in 2025 and is projected to reach USD 20.35 billion by 2035, growing at around 6.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of ultrasound is evaluated at USD 11.19 billion.
The globally increasing prevalence of chronic diseases such as chronic obstructive pulmonary disease (COPD), cancer, and arthritis are influencing the market growth. Ultrasound provides effective palliative and curative care to cancer patients and has fewer adverse effects than surgical or conventional pharmacological treatments. According to a World Health Organization (WHO) 2024 study, the global burden of new cancer cases will be 35 million in 2050, at a growth rate of 77% as compared to 20 new million cases in 2022. Furthermore, a 2023 report by the World Heart Federation mentioned 20.5 million deaths worldwide in 2021 due to cardiovascular diseases. Significant strides have been made to address the gaps in modern ultrasound technology. In September 2021, the Focused Ultrasound Foundation (FUS), Cancer Research Institute (CRI), and Parker Institute for Cancer Immunotherapy (PICI) collaborated to discuss the ongoing challenges in immuno-oncology and develop the FUS technology. It offers a targeted approach using histotripsy ablation for tumor diffusion and kills cancer cells at an early stage. The rising incidence of chronic diseases and the continuous technological advancements in non-invasive therapeutics are driving market expansion.
